Eptinezumab Completed Phase 3 Trials for Medication Overuse Headache / Migraine Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04772742Eptinezumab in Adults With Migraine and Medication Overuse Headache